BioGaia AB (publ) (ADR)
General ticker "BIOGY" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $1.0B (TTM average)
BioGaia AB (publ) (ADR) follows the US Stock Market performance with the rate: 3.0%.
Estimated limits based on current volatility of 0.0%: low 10.35$, high 10.35$
Factors to consider:
- Company pays dividends (annually): last record date 2025-05-09, amount 0.71$ (Y6.86%)
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.09$, 12.41$]
- 2025-12-31 to 2026-12-31 estimated range: [6.78$, 11.94$]
Financial Metrics affecting the BIOGY estimates:
- Positive: with PPE of 2.8 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 29.76 > 18.64
- Negative: negative Industry operating cash flow (median)
- Positive: Return on assets ratio (scaled to [-100,100]) of 14.73 > 6.04
- Positive: 0.33 < Operating cash flow per share per price, % of 3.40
- Positive: Investing cash flow per share per price, % of -0.13 > -0.66
- Positive: Interest expense per share per price, % of 0.14 <= 0.79
- Negative: negative Industry operating income (median)
- Negative: Shareholder equity ratio, % of 84.76 > 63.39
Short-term BIOGY quotes
Long-term BIOGY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | SEK1,103.96MM | SEK1,296.51MM | SEK1,422.72MM |
| Operating Expenses | SEK742.50MM | SEK853.40MM | SEK999.35MM |
| Operating Income | SEK361.46MM | SEK443.10MM | SEK423.37MM |
| Non-Operating Income | SEK86.15MM | SEK25.73MM | SEK24.45MM |
| Interest Expense | SEK5.39MM | SEK0.81MM | SEK14.92MM |
| R&D Expense | SEK106.81MM | SEK106.78MM | SEK157.10MM |
| Income(Loss) | SEK447.61MM | SEK468.83MM | SEK447.82MM |
| Taxes | SEK73.84MM | SEK103.48MM | SEK96.43MM |
| Profit(Loss)* | SEK386.09MM | SEK287.60MM | SEK279.40MM |
| Stockholders Equity | SEK1,972.42MM | SEK2,030.34MM | SEK1,723.93MM |
| Inventory | SEK142.84MM | SEK181.20MM | SEK0.00MM |
| Assets | SEK2,213.97MM | SEK2,333.19MM | SEK2,034.01MM |
| Operating Cash Flow | SEK318.94MM | SEK425.96MM | SEK373.22MM |
| Capital expenditure | SEK17.92MM | SEK48.71MM | SEK14.15MM |
| Investing Cash Flow | SEK-18.14MM | SEK-50.94MM | SEK-14.07MM |
| Financing Cash Flow | SEK-313.59MM | SEK-308.42MM | SEK-689.72MM |
| Earnings Per Share** | SEK3.82 | SEK2.85 | SEK2.76 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.